Private Capital Group, LLC Myriad Genetics Inc Transaction History

Private Capital Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $146 - $191	-13 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$9.78 - $29.53 $352 - $1,063	-36 Reduced 73.47%	13 $0
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $293 - $491	-14 Reduced 22.22%	49 $1,000
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $4,703 - $10,028	-213 Reduced 77.17%	63 $2,000
Q2 2019 Aug 15, 2019	BUY	$22.67 - $35.0 $4,828 - $7,455	213 Added 338.1%	276 $10,000
Q1 2019 Apr 26, 2019	BUY	$26.93 - $34.7 $134 - $173	5 Added 8.62%	63 $2,000
Q4 2018 Jan 28, 2019	SELL	$27.23 - $45.56 $6,153 - $10,296	-226 Reduced 79.58%	58 $2,000
Q3 2018 Oct 31, 2018	BUY	$37.57 - $50.34 $300 - $402	8 Added 2.9%	284 $13,000
Q2 2018 Aug 09, 2018	BUY	$27.75 - $40.17 $7,659 - $11,086	276 New	276 $10,000

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.21B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.